Hepatopulmonary syndrome and portopulmonary hypertension are cardiopulmonary
complications, which are not infrequently seen in patients with liver disease and/or portal …

Pulmonary hypertension is associated with diverse cardiac, pulmonary, and systemic
diseases in neonates, infants, and older children and contributes to significant morbidity and …

Patients with cirrhosis and portal hypertension are at an increased risk of the development of
circulatory dysfunction that may potentially result in multiple organ failure. Apart from the …

The objectives of this study are to evaluate trace elements in patients with liver cirrhosis and
to assess their association with severity of the disease. One hundred fifty cirrhotic subjects of …

Portopulmonary hypertension is a serious complication of portal hypertension that is
associated with significant mortality. It refers to the presence of pulmonary arterial …

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are
pulmonary vascular complications of portal hypertension with divergent clinicopathologic …

Abstract Background & Aims Extrahepatic complications of cirrhosis increase the risk for
decompensation of the liver disease and death. Previous studies show common …

The major drawback of the current common bile duct ligation (CBDL)-induced
hepatopulmonary syndrome (HPS) animal model is the extremely high mortality rate that …

Abstract Background & Aims Hepatopulmonary syndrome in children has not been
extensively studied particularly in different subsets of portal hypertension. We prospectively …

Fractional exhaled nitric oxide (FeNO) is a convenient, non-invasive method for the
assessment of active, mainly Th2-driven, airway inflammation, which is sensitive to treatment …